Golar LNG Limited: Fortuna FLNG Offtake Awarded to Gunvor
Aug 21, 2017 12:01 pm UTC| Business
The Ministry of Mines and Hydrocarbons ("MMH"), Ophir Equatorial Guinea (Block R) Ltd, OneLNG SA and La Compania Nacional De Petroleos De Guinea Ecuatorial ("GEPetrol") have nominated Gunvor Group Ltd ("Gunvor") as its...
ASML reports transactions under its current share buyback program
Aug 21, 2017 12:01 pm UTC| Business
VELDHOVEN, the Netherlands - ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average price Total repurchased...
Aug 21, 2017 12:01 pm UTC| Business
Weston, Florida , Aug. 21, 2017 -- Petrone Worldwide, Inc. to Launch Highly Customized, Feature-Rich, and Immersive Ecommerce Site for Retail Sales Weston, Florida – August 21, 2017. Petrone Worldwide, Inc. (OTCQB:...
Uranium Resources Changes its Name to Westwater Resources and Announces New Chairman
Aug 21, 2017 12:01 pm UTC| Business
CENTENNIAL, Colo., Aug. 21, 2017 -- Westwater Resources, Inc. (Nasdaq:WWR) (ASX:URI), formerly Uranium Resources, Inc. (Nasdaq:URRE) (ASX:URI), an energy metals exploration and development company, is pleased to...
Semtech’s Neo-Iso™ Platform Supports High Load Current HVAC and Industrial Applications
Aug 21, 2017 12:01 pm UTC| Business
CAMARILLO, Calif., Aug. 21, 2017 -- Semtech Corporation (Nasdaq: SMTC), a leading supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, announced the availability of its new...
Aug 21, 2017 12:00 pm UTC| Business
MORRIS PLAINS, N.J., Aug. 21, 2017 -- Immunomedics, Inc. (NASDAQ:IMMU) (“Immunomedics” or the “Company”) today announced that labetuzumab govitecan (IMMU-130), the second agent from its first-in-class antibody-drug...
Altimmune Submits Investigational New Drug Application for NasoVAX in Preparation for Phase 2 Trial
Aug 21, 2017 12:00 pm UTC| Business
60 volunteers to be enrolled Data expected in the first quarter of 2018 GAITHERSBURG, Md., Aug. 21, 2017 -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced the Company has...